Lotifazole

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H9Cl3N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1B3TF200TI, chemically known as 2,2,2-trichloroethyl (4-phenyl-2-thiazolyl)carbamate but generally known as lotifazole, which bears US NIH Compound Identifier 68905. European Medicines Agency schedules Lotifazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08600MIG. The term LOTIFAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). LOTIFAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lotifazole under HS 29341000 and SITC 51579. As of Q4 2014, LOTIFAZOLE remains the US FDA Preferred Term for this commodity. Lotifazole bears US NLM identifiers UMLS ID C0164084 and NCI Concept Code C66037. SMILES: CLC(CL)(CL)COC(=O)NC1SCC(N1)C1CCCCC1.